Diabetes and bone health: latest evidence and clinical implications. - Wikidata - awgldk - TriplyDB

Diabetes and bone health: latest evidence and clinical implications.

Diabetes and bone health: latest evidence and clinical implications.

http://www.wikidata.org/entity/Q37698523

about

The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.Osteoporosis knowledge and beliefs in diabetic patients: a cross sectional study from Palestine.

P2860

Q47707495-936A49DC-46EF-45E3-9DC5-613601E55838 Q50131165-BCF16FCA-DB3E-46C2-883A-E3E475B2EC56

P2860

Diabetes and bone health: latest evidence and clinical implications.

http://www.wikidata.org/entity/Q37698523

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Diabetes and bone health: latest evidence and clinical implications.

@en

Diabetes and bone health: latest evidence and clinical implications.

@nl

type

label

Diabetes and bone health: latest evidence and clinical implications.

@en

Diabetes and bone health: latest evidence and clinical implications.

@nl

prefLabel

Diabetes and bone health: latest evidence and clinical implications.

@en

Diabetes and bone health: latest evidence and clinical implications.

@nl

P1433

Q37698523-5887EDB4-CE0E-4AA4-8347-7686697C3772

P1476

Q37698523-008381D7-92C9-4627-B982-8A371C23B455

P2093

Q37698523-25ADB789-0F4A-4427-AE62-2F225B5598F3

Q37698523-2B61D1E6-C301-4506-871E-08A296C738E1

Q37698523-88D7BE38-CF21-45E0-9357-EB6B7A53D9F9

Q37698523-A24C9C0E-4B6F-48F4-9C29-979BFE213633

Q37698523-AFDB806F-BFFA-40B7-B453-D7FEC115C747

P2860

Q37698523-064E7DAB-9A9E-430E-9283-3765816C8A7C

Q37698523-0A29EDCB-C2B6-483C-8BAA-5DE89C596EFD

Q37698523-0BE642F5-CCE7-4C03-B94A-7830ADF3F4F3

Q37698523-14453CC3-6BA2-4438-85A5-18F3D2629F77

Q37698523-1F041E3E-178C-44A4-B643-BC04DFE1C662

Q37698523-268934B1-2F90-4536-BAF3-F05A6A7A8673

Q37698523-27216ACC-0A82-4BED-A4A8-EC78FEE53464

Q37698523-28A13A8C-4F28-4F40-9760-7C6DFF74F076

Q37698523-31C9AB8E-78EE-464C-87DA-36047394CD28

Q37698523-38060AA0-841A-4799-AFEA-91FE2E73F929

P304

Q37698523-8A8A518D-6D6D-433E-9E30-793E82D6DD6F

P31

Q37698523-F81F0003-2ABF-4DFF-A367-D317121374F1

P356

Q37698523-ABDEBA8C-5B1E-4790-9FEE-6B327D242C4A

P433

Q37698523-05B72639-F756-4ED2-82F1-4FA8519C88AC

P478

Q37698523-5ECAC210-C88A-4D48-AB3D-24CA647A734A

P577

Q37698523-0A6D323F-48E1-4358-B870-FFB596ABEAD2

P698

Q37698523-38633DBB-4A0C-417D-A32E-44308521D7A7

P932

Q37698523-FF0C68F6-08DA-4D99-9EF7-F95DED236366

P356

1759720X16687480

P1433

Therapeutic advances in musculoskeletal disease

P1476

Diabetes and bone health: latest evidence and clinical implications.

@en

P2093

Brad Evans

http://www.w3.org/2001/XMLSchema#string

Jiayong Liu

http://www.w3.org/2001/XMLSchema#string

Matthew M Mazur

http://www.w3.org/2001/XMLSchema#string

Nabil A Ebraheim

http://www.w3.org/2001/XMLSchema#string

Vikram Sundararaghavan

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular and molecular mechanisms of metformin: an overview

Pharmacology, physiology, and mechanisms of incretin hormone action

Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Type 1 diabetes

Diabetes, biochemical markers of bone turnover, diabetes control, and bone

Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.

Chemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: clues for assessing potential for cardiotoxicity.

Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.

P304

67-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1759720X16687480

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28344668

http://www.w3.org/2001/XMLSchema#string

P932

5349336

http://www.w3.org/2001/XMLSchema#string